B. AYDIN And B. TURANLI, "Multi-Omics Data Integration to Unveil Molecular Signatures and Repositioned Therapeutics in Pituitary Neuroendocrine Tumors," BIOINFO 2022 Annual Conference , Daejeon, South Korea, 2022
AYDIN, B. And TURANLI, B. 2022. Multi-Omics Data Integration to Unveil Molecular Signatures and Repositioned Therapeutics in Pituitary Neuroendocrine Tumors. BIOINFO 2022 Annual Conference , (Daejeon, South Korea).
AYDIN, B., & TURANLI, B., (2022). Multi-Omics Data Integration to Unveil Molecular Signatures and Repositioned Therapeutics in Pituitary Neuroendocrine Tumors . BIOINFO 2022 Annual Conference, Daejeon, South Korea
AYDIN, BÜŞRA, And BESTE TURANLI. "Multi-Omics Data Integration to Unveil Molecular Signatures and Repositioned Therapeutics in Pituitary Neuroendocrine Tumors," BIOINFO 2022 Annual Conference, Daejeon, South Korea, 2022
AYDIN, BÜŞRA And TURANLI, BESTE. "Multi-Omics Data Integration to Unveil Molecular Signatures and Repositioned Therapeutics in Pituitary Neuroendocrine Tumors." BIOINFO 2022 Annual Conference , Daejeon, South Korea, 2022
AYDIN, B. And TURANLI, B. (2022) . "Multi-Omics Data Integration to Unveil Molecular Signatures and Repositioned Therapeutics in Pituitary Neuroendocrine Tumors." BIOINFO 2022 Annual Conference , Daejeon, South Korea.
@conferencepaper{conferencepaper, author={BÜŞRA AYDIN And author={BESTE TURANLI}, title={Multi-Omics Data Integration to Unveil Molecular Signatures and Repositioned Therapeutics in Pituitary Neuroendocrine Tumors}, congress name={BIOINFO 2022 Annual Conference}, city={Daejeon}, country={South Korea}, year={2022}}